Cynosure Lutronic reports accelerating adoption of its XERF monopolar radiofrequency platform across North American medspas and aesthetic practices. The device is positioned as a leading fractional RF option in a market segment dominated by InMode's Forma, Cutera's Xeo, and Synergist platforms.
Devices & Tech
Cynosure Lutronic's XERF Monopolar RF Platform Gains Rapid Adoption Across North America
Fractional RF device shows accelerating uptake in the competitive energy-device market.
XERF monopolar RF adoption accelerates, intensifying competition in the fractional RF segment and compressing device acquisition economics.
Monopolar RF devices target skin tightening and collagen remodeling with lower downtime than ablative lasers, making them high-margin consumable-light procedures for practices. XERF's uptake reflects both competitive pricing and Cynosure Lutronic's distribution strength through existing laser and light-source relationships. For practices evaluating RF platforms, the competitive intensity in fractional RF—with multiple cleared devices and aggressive marketing—continues to compress acquisition costs and service terms, but also fragments the installed base and complicates vendor lock-in strategies.
Source: original report ↗
Free alerts
Free: recall & rule-change alerts for your practice.
Get the recalls and state-law changes that hit your treatment room, in your inbox — free. Unsubscribe in one click.
Free · weekly · unsubscribe anytime. Privacy.
Stay three moves ahead of every practice in your market.
Knowing it happened is table stakes. Inside MedSpa Pro hands you the play — what each move means for your margins, your license, and your patients, and exactly what to do about it — in a two-minute brief, twice a week. The owners who read it never get blindsided.
Get the edge · $20/moJoin the owners who run ahead of the industry. Cancel anytime, one click.